Follow
Ting Zhong
Title
Cited by
Cited by
Year
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
Y Zhao, W Ren, T Zhong, S Zhang, D Huang, Y Guo, X Yao, C Wang, ...
Journal of controlled release 222, 56-66, 2016
2512016
The development of site-specific drug delivery nanocarriers based on receptor mediation
X Wang, S Li, Y Shi, X Chuan, J Li, T Zhong, H Zhang, W Dai, B He, ...
Journal of controlled release 193, 139-153, 2014
1212014
The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles
XC Zheng, W Ren, S Zhang, T Zhong, XC Duan, YF Yin, MQ Xu, YL Hao, ...
International Journal of Nanomedicine, 1495-1504, 2018
1032018
A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic
T Zhong, X Yao, S Zhang, Y Guo, XC Duan, W Ren, D Huang, YF Yin, ...
Scientific reports 6 (1), 36614, 2016
702016
The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
C Wang, X Wang, T Zhong, Y Zhao, WQ Zhang, W Ren, D Huang, ...
International journal of nanomedicine, 2229-2248, 2015
682015
Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma
R Du, T Zhong, WQ Zhang, P Song, WD Song, Y Zhao, C Wang, YQ Tang, ...
International Journal of Nanomedicine, 3091-3105, 2014
582014
Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy
D Huang, S Zhang, T Zhong, W Ren, X Yao, Y Guo, XC Duan, YF Yin, ...
Oncotarget 7 (28), 43616, 2016
322016
Improving anti-tumor activity of sorafenib tosylate by lipid-and polymer-coated nanomatrix
Y Guo, T Zhong, XC Duan, S Zhang, X Yao, YF Yin, D Huang, W Ren, ...
Drug Delivery 24 (1), 270-277, 2017
272017
Effect of XlogP and Hansen solubility parameters on small molecule modified paclitaxel anticancer drug conjugates self-assembled into nanoparticles
T Zhong, YL Hao, X Yao, S Zhang, XC Duan, YF Yin, MQ Xu, Y Guo, ZT Li, ...
Bioconjugate Chemistry 29 (2), 437-444, 2018
262018
Improving solubility and oral bioavailability of febuxostat by polymer-coated nanomatrix
YF Yin, Y Guo, WD Song, XC Duan, XC Zheng, T Zhong, S Zhang, X Yao, ...
Aaps Pharmscitech 19, 934-940, 2018
152018
Thermosensitive and antioxidant wound dressings capable of adaptively regulating TGFβ pathways promote diabetic wound healing
H Niu, Y Guan, T Zhong, L Ma, M Zayed, J Guan
NPJ Regenerative Medicine 8 (1), 32, 2023
142023
Antitumor Activity of the Zinc Oxide Nanoparticles Coated with Low-Molecular-Weight Heparin and Doxorubicin Complex In Vitro and In Vivo
Z Li, S Zhang, M Liu, T Zhong, H Li, J Wang, H Zhao, Y Tian, H Wang, ...
Molecular Pharmaceutics 19 (11), 4179-4190, 2022
122022
Does ligand–receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?
WQ Zhang, KF Yu, T Zhong, LM Luo, R Du, W Ren, D Huang, P Song, ...
Journal of drug targeting 23 (10), 897-909, 2015
112015
The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug
P Song, X Yao, T Zhong, S Zhang, Y Guo, W Ren, D Huang, XC Duan, ...
Oncotarget 7 (30), 48467, 2016
92016
Co-delivery of bioengineered exosomes and oxygen for treating critical limb ischemia in diabetic mice
T Zhong, N Gao, Y Guan, Z Liu, J Guan
ACS nano 17 (24), 25157-25174, 2023
82023
The preparation and characteristics of febuxostat SiO2 solid dispersions
W Song, R Du, P Song, T Zhong, W Zhang, Y Zhao, C Wang, X Zhang, ...
Journal of Chinese Pharmaceutical Sciences 23 (7), 463, 2014
72014
The cellular uptake and anti-tumor activity of conjugated linoleic acid-paclitaxel-loaded iRGD-modified lysolipid-containing thermosensitive liposomes.
Y Hao, T Zhong, R Du, H Zhang, B Liu, X Zhang
Journal of Chinese Pharmaceutical Sciences 28 (2), 2019
42019
Effect of XlogP and Hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles
MQ Xu, T Zhong, X Yao, ZY Li, H Li, JR Wang, ZH Feng, X Zhang
Drug Delivery 28 (1), 1603-1615, 2021
22021
The preparation and characteristics of sterically stabilized liposomes containing paclitaxel and super-paramagnetic iron oxide nanoparticles
W Ren, S Zhang, T Zhong, D Huang, X Yao, Y Guo, X Duan, Y Yin, ...
Journal of Chinese Pharmaceutical Sciences 25 (8), 570, 2016
22016
Structure of the Conjugated Linoleic Acid-Paclitaxel Conjugate Self-Assembled Nanoparticles
ZHENG Xiu-chai, XU Mei-qi, LIU Man, ZHONG Ting, HAO Yan-li, ZHANG Shuang, LI ...
Chinese pharmaceutical Journal 54 (21), 1752-1757, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20